Biggest banks planning to sue the Federal Reserve over annual stress tests

Biggest banks planning to sue the Federal Reserve over annual stress tests


A general view of the Federal Reserve Building in Washington, United States.
Samuel Corum | Anadolu Agency | Getty Images

The biggest banks are planning to sue the Federal Reserve over the annual bank stress tests, according to a person familiar with the matter. A lawsuit is expected this week and could come as soon as Tuesday morning, the person said.

The Fed’s stress test is an annual ritual that forces banks to maintain adequate cushions for bad loans and dictates the size of share repurchases and dividends.

After the market close on Monday, the Federal Reserve announced in a statement that it is looking to make changes to the bank stress tests and will be seeking public comment on what it calls “significant changes to improve the transparency of its bank stress tests and to reduce the volatility of resulting capital buffer requirements.”

The Fed said it made the determination to change the tests because of “the evolving legal landscape,” pointing to changes in administrative laws in recent years. It didn’t outline any specific changes to the framework of the annual stress tests.

While the big banks will likely view the changes as a win, it may be too little too late.

Also, the changes may not go far enough to satisfy the banks’ concerns about onerous capital requirements. “These proposed changes are not designed to materially affect overall capital requirements, according to the Fed.

The CEO of BPI (Bank Policy Institute), Greg Baer, which represents big banks like JPMorgan, Citigroup and Goldman Sachs, welcomed the Fed announcement, saying in a statement “The Board’s announcement today is a first step towards transparency and accountability.”

However, Baer also hinted at further action: “We are reviewing it closely and considering additional options to ensure timely reforms that are both good law and good policy.”

Groups like the BPI and the American Bankers Association have raised concerns about the stress test process in the past, claiming that it is opaque, and has resulted in higher capital rules that hurt bank lending and economic growth.

In July, the groups accused the Fed of being in violation of the Administrative Procedure Act, because it didn’t seek public comment on its stress scenarios and kept supervisory models secret.

CNBC’s Hugh Son contributed to this report.



Source

David Einhorn says the Fed will cut ‘substantially more’ than two times. So he’s betting big on gold
Finance

David Einhorn says the Fed will cut ‘substantially more’ than two times. So he’s betting big on gold

Key Points David Einhorn of Greenlight Capital anticipates the Federal Reserve will cut more than twice in 2026, which is what traders have priced in. Einhorn owns gold and Secured Overnight Financing Rate, or SOFR, futures. Gold has seen massive gains in recent years, though it faced some pressure last month following President Donald Trump’s […]

Read More
Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more
Finance

Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more

Check out the companies making headlines in midday trading: Acadia Healthcare — The health-care stock popped 10% after investor David Einhorn told CNBC that he has been buying the stock. The Greenlight Capital fund manager said he’s hopeful the company’s new management will be able to improve its performance. Vertiv — The provider of data […]

Read More
Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more
Finance

Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more

Check out the companies making headlines before the bell: Moderna — Shares tumbled 10% after the pharma giant said the Food and Drug Administration refused to review its application for an experimental flu shot, mRNA-1010. Moderna said it has requested a meeting with the FDA to “understand the path forward.” Humana — The health insurance company […]

Read More